Literature DB >> 17562092

Microscopic regional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to outcomes.

Nobuyuki Wada1, Nobuyasu Suganuma, Hirotaka Nakayama, Katsuhiko Masudo, Yasushi Rino, Munetaka Masuda, Toshio Imada.   

Abstract

AIM: The aim of this study was to evaluate microscopic nodal status in papillary thyroid carcinoma (PTC) with and without lymphadenopathy and its relation to outcomes.
MATERIALS AND METHODS: We retrospectively analyzed 134 patients with PTC who underwent initial thyroidectomy. Forty-two patients with lymphadenopathy underwent therapeutic modified neck dissection (MND) and 92 without lymphadenopathy underwent prophylactic MND. The frequencies, numbers, and percentages of lymph node metastasis (LNM) were determined to evaluate nodal status; then, whether each nodal status influence to outcomes was analyzed. Disease-free survival (DFS) and disease-specific survival (DSS) were assessed (Kaplan-Meier method and log-rank test).
RESULTS: Lymphadenopathy was significantly related to local recurrence and DFS, but not DSS. The frequency (100 vs 67.4%), number (15.8 vs 2.7), and percentage (49.7 vs 17.8%) were significantly higher in patients with lymphadenopathy than in those without lymphadenopathy (p < 0.0001). Similarly, these were significantly higher in patients who developed recurrence than in those who did not. Recurrence was frequent in older patients with lymphadenopathy. The frequency, number, and percentage were also higher in older patients who developed local recurrence.
CONCLUSIONS: Lymphadenopathy and microscopic nodal status are significantly related to recurrence. Only a few nodes seem to be involved pathologically when no lymphadenopathy.

Entities:  

Mesh:

Year:  2007        PMID: 17562092     DOI: 10.1007/s00423-007-0159-4

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  20 in total

1.  A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period.

Authors:  Iwao Sugitani; Nobukatsu Kasai; Yoshihide Fujimoto; Akio Yanagisawa
Journal:  Surgery       Date:  2004-02       Impact factor: 3.982

2.  Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989.

Authors:  I D Hay; E J Bergstralh; C S Grant; B McIver; G B Thompson; J A van Heerden; J R Goellner
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

3.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

4.  Neck dissection for surgical treatment of lymphnode metastasis in papillary thyroid carcinoma.

Authors:  M Ducci; M Appetecchia; M Marzetti
Journal:  J Exp Clin Cancer Res       Date:  1997-09

5.  Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid.

Authors:  R Sivanandan; K C Soo
Journal:  Br J Surg       Date:  2001-09       Impact factor: 6.939

6.  Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer.

Authors:  Francoise Borson-Chazot; Sylvain Causeret; Jean-Christophe Lifante; Marylin Augros; Nicole Berger; Jean-Louis Peix
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

7.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

8.  Patterns of lateral neck metastasis in papillary thyroid carcinoma.

Authors:  Michael E Kupferman; Michael Patterson; Susan J Mandel; Virginia LiVolsi; Randal S Weber
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-07

9.  Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer.

Authors:  G F Scheumann; O Gimm; G Wegener; H Hundeshagen; H Dralle
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

10.  Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma.

Authors:  K Sugino; Y Kure; H Iwasaki; O Ozaki; T Mimura; A Matsumoto; K Ito
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

View more
  19 in total

1.  In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.

Authors:  Mauricio A Moreno; Beth S Edeiken-Monroe; Eric R Siegel; Steven I Sherman; Gary L Clayman
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

2.  MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.

Authors:  Adriana Sondermann; Flavia Maziero Andreghetto; Ana Carolina Bernardini Moulatlet; Elivane da Silva Victor; Marilia Germanos de Castro; Fábio Daumas Nunes; Lenine Garcia Brandão; Patricia Severino
Journal:  Clin Exp Metastasis       Date:  2015-05-26       Impact factor: 5.150

3.  Role of prophylactic central neck dissection in cN0 papillary thyroid cancer.

Authors:  S Costa; G Giugliano; L Santoro; A Ywata De Carvalho; M A Massaro; B Gibelli; E De Fiori; E Grosso; M Ansarin; L Calabrese
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-04       Impact factor: 2.124

Review 4.  New developments in the diagnosis and treatment of thyroid cancer.

Authors:  David F Schneider; Herbert Chen
Journal:  CA Cancer J Clin       Date:  2013-06-24       Impact factor: 508.702

5.  Patterns of lymph node metastases in papillary thyroid carcinoma: results from consecutive bilateral cervical lymph node dissection.

Authors:  Hideki Takada; Toyone Kikumori; Tsuneo Imai; Masataka Sawaki; Arihiro Shibata; Tetsuya Kiuchi
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

Review 6.  New insights in risk stratification of differentiated thyroid cancer.

Authors:  Maria Papaleontiou; Megan R Haymart
Journal:  Curr Opin Oncol       Date:  2014-01       Impact factor: 3.645

7.  Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography.

Authors:  Iwao Sugitani; Yoshihide Fujimoto; Keiko Yamada; Noriko Yamamoto
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

8.  Lymph node ratio predicts recurrence in papillary thyroid cancer.

Authors:  David F Schneider; Haggi Mazeh; Herbert Chen; Rebecca S Sippel
Journal:  Oncologist       Date:  2013-01-23

Review 9.  The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancer.

Authors:  Ai Chen Chan; Brian Hung Hin Lang; Kai Pun Wong
Journal:  Gland Surg       Date:  2013-11

10.  Thyroid carcinoma after treatment for malignancies in childhood and adolescence: from diagnosis through follow-up.

Authors:  Marta Giorgia Podda; Monica Terenziani; Lorenza Gandola; Paola Collini; Natalia Pizzi; Alfonso Marchianò; Carlo Morosi; Roberto Luksch; Andrea Ferrari; Michela Casanova; Filippo Spreafico; Daniela Polastri; Cristina Meazza; Serena Catania; Elisabetta Schiavello; Veronica Biassoni; Maura Massimino
Journal:  Med Oncol       Date:  2014-07-12       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.